Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer
- PMID: 23132392
- PMCID: PMC3493861
- DOI: 10.1038/bjc.2012.428
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer
Abstract
Background: Mediator complex participates in transcriptional regulation by connecting regulatory DNA sequences to the RNA polymerase II initiation complex. Recently, we discovered through exome sequencing that as many as 70% of uterine leiomyomas harbour specific mutations in exon 2 of mediator complex subunit 12 (MED12). In this work, we examined the role of MED12 exon 2 mutations in other tumour types.
Methods: The frequency of MED12 exon 2 mutations was analysed in altogether 1158 tumours by direct sequencing. The tumour spectrum included mesenchymal tumours (extrauterine leiomyomas, endometrial polyps, lipomas, uterine leiomyosarcomas, other sarcomas, gastro-intestinal stromal tumours), hormone-dependent tumours (breast and ovarian cancers), haematological malignancies (acute myeloid leukaemias, acute lymphoid leukaemias, myeloproliferative neoplasms), and tumours associated with abnormal Wnt-signalling (colorectal cancers (CRC)).
Results: Five somatic alterations were observed: three in uterine leiomyosarcomas (3/41, 7%; Gly44Ser, Ala38_Leu39ins7, Glu35_Leu36delinsVal), and two in CRC (2/392, 0.5%; Gly44Cys, Ala67Val).
Conclusion: Somatic MED12 exon 2 mutations were observed in uterine leiomyosarcomas, suggesting that a subgroup of these malignant tumours may develop from a leiomyoma precursor. Mutations in CRC samples indicate that MED12 may, albeit rarely, contribute to CRC tumorigenesis.
Figures

Similar articles
-
Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas.Hum Mutat. 2014 Sep;35(9):1136-41. doi: 10.1002/humu.22612. Epub 2014 Jul 21. Hum Mutat. 2014. PMID: 24980722
-
Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.Fertil Steril. 2017 Feb;107(2):457-466.e9. doi: 10.1016/j.fertnstert.2016.10.035. Epub 2016 Nov 23. Fertil Steril. 2017. PMID: 27889101
-
MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma.Mod Pathol. 2014 Aug;27(8):1144-53. doi: 10.1038/modpathol.2013.243. Epub 2014 Jan 3. Mod Pathol. 2014. PMID: 24390224 Free PMC article.
-
MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives.Eur J Cancer. 2015 Aug;51(12):1603-10. doi: 10.1016/j.ejca.2015.04.023. Epub 2015 May 30. Eur J Cancer. 2015. PMID: 26037152 Review.
-
Genomics of uterine leiomyomas: insights from high-throughput sequencing.Fertil Steril. 2014 Sep;102(3):621-9. doi: 10.1016/j.fertnstert.2014.06.050. Epub 2014 Aug 5. Fertil Steril. 2014. PMID: 25106763 Review.
Cited by
-
Mediator kinase module and human tumorigenesis.Crit Rev Biochem Mol Biol. 2015;50(5):393-426. doi: 10.3109/10409238.2015.1064854. Epub 2015 Jul 16. Crit Rev Biochem Mol Biol. 2015. PMID: 26182352 Free PMC article. Review.
-
Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19.J Biol Chem. 2018 Mar 30;293(13):4870-4882. doi: 10.1074/jbc.RA118.001725. Epub 2018 Feb 13. J Biol Chem. 2018. PMID: 29440396 Free PMC article.
-
A putative competing endogenous RNA network in cisplatin-resistant lung adenocarcinoma cells identifying potentially rewarding research targets.Oncol Lett. 2020 Jun;19(6):4040-4052. doi: 10.3892/ol.2020.11483. Epub 2020 Mar 27. Oncol Lett. 2020. PMID: 32382346 Free PMC article.
-
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.Nat Genet. 2016 Oct;48(10):1253-9. doi: 10.1038/ng.3651. Epub 2016 Aug 22. Nat Genet. 2016. PMID: 27548314 Free PMC article.
-
Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia.Oncotarget. 2015 Jan 30;6(3):1884-8. doi: 10.18632/oncotarget.2753. Oncotarget. 2015. PMID: 25595892 Free PMC article.
References
-
- Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, White TA, Stojanov P, Van Allen E, Stransky N, Nickerson E, Chae SS, Boysen G, Auclair D, Onofrio RC, Park K, Kitabayashi N, MacDonald TY, Sheikh K, Vuong T, Guiducci C, Cibulskis K, Sivachenko A, Carter SL, Saksena G, Voet D, Hussain WM, Ramos AH, Winckler W, Redman MC, Ardlie K, Tewari AK, Mosquera JM, Rupp N, Wild PJ, Moch H, Morrissey C, Nelson PS, Kantoff PW, Gabriel SB, Golub TR, Meyerson M, Lander ES, Getz G, Rubin MA, Garraway LA (2012) Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 44: 685–689 - PMC - PubMed
-
- Christacos NC, Quade BJ, Dal Cin P, Morton CC (2006) Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features. Genes Chromosomes Cancer 45: 304–312 - PubMed
-
- Dave UP, Akagi K, Tripathi R, Cleveland SM, Thompson MA, Yi M, Stephens R, Downing JR, Jenkins NA, Copeland NG (2009) Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy. PLoS Genet 5: e1000491. - PMC - PubMed
-
- Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188: 100–107 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical